Katharine Head

Permanent URI for this collection

https://hdl.handle.net/1805/26676

What is motivating parents' COVID-19 vaccination decisions? A Statewide Survey of Indiana Parents

The COVID-19 vaccine is already available to children over 12 years old, and it will soon be available for children 5- 11 years old. Professor Katharine Head and her research partner, Professor Nir Menachemi, wanted to understand Hoosier parents’ perceptions of the COVID-19 vaccine and assess their intentions to get their children vaccinated. This sort of information can assist state and local governments, public health agencies, and community organizations in crafting targeted educational campaigns and other strategies that will assure high uptake of the vaccine among children.

 

They worked with the Indiana Department of Health and the Indiana Department of Education to recruit parents and caregivers across Indiana to fill out a web-based survey that assessed their perceptions about the COVID-19 vaccination. Over 10,000 parents filled out the anonymous survey! Some of the key findings include that only about 45% of parents have or intend to vaccinate their children, while about 42% do not intend to vaccinate. About 13% of parents who said they would “wait and see.” Of those wait and see parents, the researchers found some interesting perceptions about the vaccine that may suggest ways they can develop targeted educational messages to hopefully encourage them to get vaccinated, such as their perceptions of safety, perceptions of what other parents are doing, and perceptions about what their healthcare provider would want them to do. Based on these findings, they have developed a set of evidence-based suggestions for designing parent and family focused COVID-19 vaccination interventions that can be implemented in communities across Indiana.

Professor Head's translation of research into strategies to increase the number of vaccinated children in the fight against COVID-19 is another excellent example of how IUPUI's faculty members are TRANSLATING their RESEARCH INTO PRACTICE.

Browse

Browsing Katharine Head by Subject "Cervical cancer screening"

Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    Persistent Disparities in Cervical Cancer Screening Uptake: Knowledge and Sociodemographic Determinants of Papanicolaou and Human Papillomavirus Testing Among Women in the United States
    (Sage, 2020) Johnson, Nicole L.; Head, Katharine J.; Foxworthy Scott, Susanna; Zimet, Gregory D.; Communication Studies, School of Liberal Arts
    Objectives: Cervical cancer is the second-most common type of cancer among women aged 15-44, and racial, ethnic, and economic disparities exist in survival rates despite widely available screening tests and early treatment options. The objective of this study was to describe the association among knowledge, sociodemographic characteristics, and cervical cancer screening, with the goal of developing interventions to prevent cervical cancer in populations at risk of the disease. Methods: In 2017, we conducted a nationwide survey of women in the United States aged ≥18 who had ever received a Papanicolaou (Pap) test (N = 630). We conducted t tests and one-way analysis of variance to determine sociodemographic differences (age, education, race, ethnicity, income, type of health insurance) in knowledge about cervical cancer screening (Pap test and human papillomavirus [HPV] test). We used logistic regressions to define significant determinants of cervical cancer screening behaviors in the previous 5 years. Results: Of 629 respondents, 407 (64.7%) had an annual household income <$30 000, and 322 of 536 (60.1%) respondents had government-provided health insurance. Of 630 women who had ever had a Pap test, 425 (67.5%) had an HPV test. Hispanic and non-Hispanic white women were more likely than Hispanic and non-Hispanic black women (odds ratio [OR] = 2.49; 95% CI, 1.12-4.54; P = .02) and women with government-provided health insurance (OR = 1.91; 95% CI, 1.08-3.37; P = .03) were more likely than women with private health insurance to have received a Pap test in the previous 5 years. Knowledge of HPV was a significant predictor of having received an HPV test in the previous 5 years (OR = 1.37; 95% CI, 1.22-1.54; P < .001). Conclusion: Disparities in cervical cancer screening among sociodemographic groups of women suggest the need for targeted interventions to improve knowledge about Pap and HPV tests.